8 pending office actions • 3 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Vertex Pharmaceuticals Incorporated | 3 |
| Viacyte, Inc. | 3 |
| Vertex Pharmaceuticals Incorporated | 2 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18647137 | STEM CELL DERIVED PANCREATIC ISLET DIFFERENTIATION | Vertex Pharmaceuticals Incorporated | DICKINSON, PAUL W | 1618 | Non-Final OA | Apr 26, 2024 |
| 18435390 | TOOLS AND INSTRUMENTS FOR USE WITH IMPLANTABLE ENCAPSULATION DEVICES | Viacyte, Inc. | COLLINS, RAVEN | 3735 | Final Rejection | Feb 07, 2024 |
| 18270314 | ENHANCED DIFFERENTIATION OF BETA CELLS | Vertex Pharmaceuticals Incorporated | MONTANARI, DAVID A | 1632 | Non-Final OA | Jun 29, 2023 |
| 18138904 | ENCAPSULATION OF PANCREATIC CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS | Viacyte, Inc. | CRAIGO, WILLIAM A | 1615 | Non-Final OA | Apr 25, 2023 |
| 18018787 | IN VITRO DIFFERENTIATION OF PANCREATIC ENDOCRINE CELLS | Vertex Pharmaceuticals Incorporated | ROGERS, ERIC JASON | 1638 | Non-Final OA | Jan 30, 2023 |
| 17894816 | CRYOPRESERVED ENDOCRINE CELLS THAT EXPRESS CHROMOGRANIN A | Viacyte, Inc. | FOX, ALLISON M | 1633 | Non-Final OA | Aug 24, 2022 |
| 17669874 | PANCREATIC DIFFERENTIATION | Vertex Pharmaceuticals Incorporated | BATES, KEENAN ALEXANDER | 1631 | Final Rejection | Feb 11, 2022 |
| 17560680 | ENHANCED DIFFERENTIATION OF BETA CELLS | Vertex Pharmaceuticals Incorporated | NGUYEN, NGHI V | 1653 | Non-Final OA | Dec 23, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial